Page 1,738«..1020..1,7371,7381,7391,740..1,7501,760..»

5 Drug Stocks in Focus on World MS Day – May 31, 2017 – Zacks.com – Zacks.com

Posted: Published on May 31st, 2017

Since 2009, World MS Day is officially marked on the last Wednesday of May with events and campaigns focused on bringing the worldwide multiple sclerosis (MS) community together and raising awareness about the disease. Life with MS This World MS Day the theme is Life with MS. About 2.3 million people across the world suffer from MS, one of the most common neurological disorders and causes of disability in young adults, while hundreds of thousands remain undiagnosed. According to the Multiple Sclerosis Foundation, more than 400,000 people in the U.S. have MS with approximately 200 new cases being diagnosed each week. There are different types of MS including primary progressive MS (PPMS), relapsing MS (RMS), the most common form of the disease, and secondary progressive MS (SPMS). The multiple sclerosis market represents huge commercial potential. According to information provided by GlobalData, the MS market is slated to grow from $17.2 billion in 2014 to about $20 billion by 2024. While there is no cure for the disease, several treatments are available to manage the disease. Competition in the MS market is intense given the presence of injectable treatments as well as oral disease-modifying therapies. Moreover, several companies are working on … Continue reading →

Posted in MS Treatment | Comments Off on 5 Drug Stocks in Focus on World MS Day – May 31, 2017 – Zacks.com – Zacks.com

European Hormone Replacement Therapy Market estimated at … – MilTech

Posted: Published on May 31st, 2017

Market Data Forecast has published a new report Europe Hormone Replacement Therapy Market, according to which the market is estimated at $4.10 billion in 2016 and poised to grow $5.68 billion by 2021 with a CAGR of 6.75% in the forecast period. Hormone replacement therapy is given to some women whose estrogen and progesterone levels drop drastically due to menopause. Hormone replacement therapy tops up a womans levels of essential hormones. These are receptors that listens signal by hormones and causes growth in women body. There are adverse effects in hormone replacement therapy like, risk of cervical cancer, breast cancer, and uterine cancer. Estrogen replacement therapy dominated the market in 2015. Also, increasing number of women reaching the menopausal age is anticipated to drive the demand for hormone replacement treatments over the forecast period. The report provides a detailed analysis of drivers and constraints that controls growth of the market. Some of the drivers are: Increasing awareness among the masses regarding post-menopause problems. Currently unmet demand of medicines and therapies. Government support in terms of policies and funding. For Full Report refer to: http://www.marketdataforecast.com/market-reports/europe-hormone- For better understanding Hormone Replacement Therapy Market is segmented by hormone type and route of administration. … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on European Hormone Replacement Therapy Market estimated at … – MilTech

Texas on track to become first state to explicitly back stem cell … – STAT

Posted: Published on May 31st, 2017

L awmakers in Austinhave approved a billauthorizing unapproved stem cell therapies, puttingTexas on track to become the first state to explicitly recognize the experimental treatments. The measure now heads to Governor Greg Abbott, who has signaled his support for it. For years, clinics across the country have been offeringexperimentalstem cell therapies for patients with chronic conditions or terminal illnesses, but no state has given them legal validation. Instead, clinics have largely operated under the radar of regulatory authorities, toutingtreatments for a range of injuries and diseases. advertisement Many scientists, meantime, have warnedthat unapproved stem cell therapies can be not only ineffective but harmful outside limited and closely watched clinical trials. Infant gets experimental stem cell injection to try to repair his heart The Texas measure was finalized Monday before the end of the Legislatures session. Senators added amendments that would require the treatments to be delivered by a doctor at a hospital or ambulatory medical center and with the approval of an institutional review board, which reviews research that involves human participants. Another amendment would allow patients to sue should the treatment go awry. Advocates who opposed the measure as it was introduced said they were still uneasy with aspects … Continue reading →

Posted in Stem Cell Research | Comments Off on Texas on track to become first state to explicitly back stem cell … – STAT

Patients’ stem cells point to potential treatments for motor neuron disease – Cosmos

Posted: Published on May 31st, 2017

Physicist Stephen Hawking is perhaps the most famous sufferer of motor neuron disease, a crippling degenerative condition that affects an estimated 150,00 people around the world. Karwai Tang / Getty In news that may bring hope to Stephen Hawking and hundreds of thousands of others around the world, British scientists have used reprogrammed skin cells to study the development of motor neuron disease. Its like changing the postcode of a house without actually moving it, explains neuroscientist Rickie Patani, referring to research offering startling new insights into the progress and treatment of the crippling degenerative condition, also known as amyotrophic lateral sclerosis (ALS). Patani, together with colleague Sonia Gandhi, both from the Francis Crick Institute and University College London, in the UK, led a team of researchers investigating how the disease destroys the nerve cells that govern muscle movement. The results, published in the journal Cell Reports, comprise the most fine-grained work to date on how ALS operates on a molecular level and suggest powerful new treatment methods based on stem cells. Indeed, so exciting are the implications of the research that Ghandi and Patani are already working with pharmaceutical companies to develop their discoveries. The neurologists uncovered two key … Continue reading →

Posted in Stem Cell Research | Comments Off on Patients’ stem cells point to potential treatments for motor neuron disease – Cosmos

Take it from a cardiologist: Tobacco sales should be restricted to 21 and over – The Journal News | LoHud.com

Posted: Published on May 31st, 2017

Dr. Patrick W. Thomas Published 7:00 p.m. ET May 30, 2017 | Updated 9 hours ago Dr. Patrick W. Thomas, chief of cardiology at New York-Presbyterian Hudson Valley Hospital, supports state legislation to raise the age for tobacco sales to 21. Dr. Thomas is also president of the Board of Directors for the Putnam County Division of the American Heart Association. Video by Nancy Cutler/lohud Wochit Those who seek support to stop smoking are more likely to succeed.(Photo: AndreyPopov, Getty Images/iStockphoto) I see it in my cardiology practice each day the deadly effects of smoking: The obvious health implications, the attempts to quitand the resignation that comes when those quitting attempts fail. Tobacco addiction causes heart disease, damage to arteries throughout the body, chronic and debilitating breathing issues, stroke, aneurysms, cancer. The list goes on. I prescribe medications (such as nicotine replacement therapies) and offer information for group or individual counseling. Most patients who smoke want to quit but the addiction is just too strong. As a health-care provider, it is my job to speak out to break the cycle of tobacco addiction, and thats exactly what legislation thats been proposed to raise the age of sale for tobacco products … Continue reading →

Posted in Cardiology | Comments Off on Take it from a cardiologist: Tobacco sales should be restricted to 21 and over – The Journal News | LoHud.com

TaiGen Biotechnology Announces Submission of New Drug Application for Taigexyn Intravenous Formulation to the … – PR Newswire (press release)

Posted: Published on May 31st, 2017

TAIPEI, Taiwan, May 30, 2017 /PRNewswire/ --TaiGen Biotechnology Company, Limited ("TaiGen") today announced that it has submitted a New Drug Application (NDA) for the intravenous formulation of Taigexyn (Nemonoxacin) to the China Food and Drug Administration (CFDA). Taigexyn is a novel non-fluorinated quinolone antibiotic.The NDA submission is supported by a pivotal Phase 3 trial comparing intravenous formulations of Taigexyn 500 mg to levofloxacin 500 mg in 518 patients with moderate to severe community-acquired pneumonia. The clinical success rates were 91.8% for Taigexyn vs. 85.7% for levofloxacin and Taigexyn was shown to be non-inferior to levofloxacin meeting the primary endpoint of the pivotal trial. About Taigexyn Taigexyn is a novel broad spectrum antibiotic with excellent efficacy against drug-resistant bacteria available in both oral and intravenous formulations. The oral formulation is already approved for marketing and launched in Taiwan and mainland China. In addition, Taigexyn is also partnered in Russia, Commonwealth Independent States, Turkey, Mexico, Brazil and the Latin American territory for a total 32 countries worldwide. Link: TaiGen Biotechnology Announces Submission of New Drug Application for Taigexyn Intravenous Formulation to the ... - PR Newswire (press release) … Continue reading →

Posted in Biotechnology | Comments Off on TaiGen Biotechnology Announces Submission of New Drug Application for Taigexyn Intravenous Formulation to the … – PR Newswire (press release)

Earnings Clues on Puma Biotechnology, Inc. (PBYI), AGNC Investment Corp. (AGNC) Analyst’s Predictions – StockNewsJournal

Posted: Published on May 31st, 2017

The Cerbat Gem Earnings Clues on Puma Biotechnology, Inc. (PBYI), AGNC Investment Corp. (AGNC) Analyst's Predictions StockNewsJournal Investors who are keeping close eye on the stock of Puma Biotechnology, Inc. (NASDAQ:PBYI) established that the company was able to keep return on investment at -163.88 in the trailing twelve month while Reuters data showed that industry's average ... Puma Biotechnology, Inc. (PBYI): A Detailed Look at its Institutional OwnershipPost Analyst Puma Biotechnology Inc (PBYI) Upgraded at Cowen and CompanyThe Cerbat Gem Puma Biotechnology (PBYI) Earning Somewhat Critical News Coverage, AlphaOne ReportsChaffey Breeze Geneva Journal -BBNS -SEC.gov -Barchart.com all 52 news articles » View original post here: Earnings Clues on Puma Biotechnology, Inc. (PBYI), AGNC Investment Corp. (AGNC) Analyst's Predictions - StockNewsJournal … Continue reading →

Posted in Biotechnology | Comments Off on Earnings Clues on Puma Biotechnology, Inc. (PBYI), AGNC Investment Corp. (AGNC) Analyst’s Predictions – StockNewsJournal

Form 8-K PUMA BIOTECHNOLOGY, INC. For: May 24 – StreetInsider.com

Posted: Published on May 31st, 2017

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May30, 2017 (May 24, 2017) PUMA BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) 10880 Wilshire Boulevard, Suite 2150 Los Angeles, California 90024 (Address of principal executive offices) (Zip Code) (424) 248-6500 (Registrants telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided … Continue reading →

Posted in Biotechnology | Comments Off on Form 8-K PUMA BIOTECHNOLOGY, INC. For: May 24 – StreetInsider.com

Utah company merging technology, biology to treat diseases – Deseret News

Posted: Published on May 31st, 2017

SALT LAKE CITY Chris Gibson is a really big thinker. The kind of thinker who strives to become an M.D. and a Ph.D at the same time. That was his plan a few years ago when he was in the University of Utah's dual degree program studying to become a cardiothoracic surgeon and a researcher. It was in the process of pursuing those degrees when he found himself in a laboratory working with Dr. Dean Li, one of the pre-eminent researchers at the school. "I had a background in bioengineering, and was working on bringing the engineering mentality to his more traditional biology and genetics lab," Gibson said. It was during that time when they were working on one disease when he made a discovery. "I noticed that when you modeled that disease in human cells, the disease cells looked really different," he explained. The difference was how the cells morphed into something that was totally unlike their original composition. That relatively minor recognition eventually became the impetus for launching a new kind of biotechnology company that combines information technology and biological research. "That's where we came up with this idea to use computer vision and machine learning to automate … Continue reading →

Posted in Biology | Comments Off on Utah company merging technology, biology to treat diseases – Deseret News

Synthetic biology Engineering complex and robust genetic circuits – Nature.com

Posted: Published on May 31st, 2017

Synthetic biology Engineering complex and robust genetic circuits Nature.com Reprogramming cells to perform desired tasks or computations is a long-standing goal in synthetic biology. Although tools are being developed at a fast pace, engineering biocomputation circuits with multiple inputs and outputs in mammalian cells ... The rest is here: Synthetic biology Engineering complex and robust genetic circuits - Nature.com … Continue reading →

Posted in Biology | Comments Off on Synthetic biology Engineering complex and robust genetic circuits – Nature.com

Page 1,738«..1020..1,7371,7381,7391,740..1,7501,760..»